Eltrombopag for thrombocytopenic patients with hepatitis C virus infection and cirrhosis

Gastroenterology

Volumn 147, Issue 1, 2014, Pages 253-254

  Ji, Fanpu ^a   Deng, Hong ^a   Li, Zongfang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BOCEPREVIR; ELTROMBOPAG; PEGINTERFERON ALPHA; RIBAVIRIN; SIMEPREVIR; SOFOSBUVIR; TELAPREVIR;

ANTIVIRAL THERAPY; ASCITES; BACTERIAL PERITONITIS; BRAIN DISEASE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER CIRRHOSIS; LIVER FIBROSIS; MULTICENTER STUDY (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PORTAL HYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THERAPY EFFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRUS LOAD;

ANTIVIRAL AGENTS; BENZOATES; FEMALE; HEMATOLOGIC AGENTS; HEPATITIS C, CHRONIC; HUMANS; HYDRAZINES; LIVER CIRRHOSIS; MALE; PYRAZOLES; THROMBOCYTOPENIA;

EID: 84902985621     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.12.046     Document Type: Letter

References (8)

1. N.H. Afdhal et al. Gastroenterology 146 2014 442 452
2. A. Iacobellis et al. Aliment Pharmacol Ther 30 2009 146 153
3. E.G. Giannini et al. J Intern Med 266 2009 537 546
4. C. Hézode et al. J Hepatol 59 2013 434 441
5. E. Ogawa et al. J Hepatol 58 2013 495 501
6. F. Ji et al. J Hepatol 58 2013 1262 1264
7. N. Ikeda et al. Hepatol Res 2013 Jun 14 10.1111/hepr.12184 [Epub ahead of print]
8. F. Ji et al. Braz J Infect Dis 17 2013 601 605